Powder: -20°C for 3 years | In solvent: -80°C for 1 year
RPR121056 is a Irinotecan metabolite, which is generated by CYP3A4. Irinotecan is an antineoplastic agent that inhibits topoisomerase type I.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
2 mg | 5 days | $ 379.00 |
Description | RPR121056 is a Irinotecan metabolite, which is generated by CYP3A4. Irinotecan is an antineoplastic agent that inhibits topoisomerase type I. |
Synonyms | APC |
Molecular Weight | 618.68 |
Formula | C33H38N4O8 |
CAS No. | 181467-56-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
RPR121056 181467-56-1 Neuroscience AChR RPR 121056 APC RPR-121056 inhibitor inhibit